期刊文献+

广东汉族人群HLA-B~* 15等位基因分布 被引量:1

HLA-B~* 15 diversity in Guangdong Han population
下载PDF
导出
摘要 目的了解广东献血者汉族人群HLA-B*15等位基因的多态性。方法从1 691名广东汉族献血者中采用中/低分辨分型获得带有HLA-B*15基因型466例样本,进一步应用PCR-SBT技术进行测序分型,获得广东汉族人群B*15高分辨分型结果。应用PyPop软件计算HLA-B*15各等位基因频率,同时与其他人群资料进行比较。结果共检测到16种已知HLA-B*15等位基因,其中以B*15∶02(64.75%)最常见,其次为B*15∶01(13.26%),B*15∶25(4.554%),B*15∶27(4.158%),B*15∶12(3.960%),这5种等位基因占B*15等位基因家族的90.69%。在B*15等位基因家族中,表达B75抗原的等位基因B*15∶02、B*15∶11和B*15∶21共占67.92%,但表达B62抗原的B*15等位基因多态性最强,共检出6种等位基因。结论广东汉族人群中HLA-B*15等位基因表现出高度的多态性及其特有的分布特征。 Objective To investigate the allele distribution of HLA-B* 15 gene family in GuangDong Han population. Methods A total of 466 samples with HLA-B* 15 genotypes were selected from 1691 GuangDong Han individuals,based on their HLA-B types determined by PCR-SSP or PCR-SSO using commercial typing kits. PCR-SBT was applied to determine HLA-B* 15 allele typing. Allele frequencies were analyzed by PyPop Software. And the chi-square values of allele frequencies from different populations were also analyzed. Results A total of 16 different HLA-B* 15 alleles were identified. B* 15:02(64.75%) was the most frequent allele,followed by B* 15:01 (13.26%),B*15:25 (4.554%) ,B* 15:27 (4. 158%),B*15: 12(3. 960%), which comprised more than 90. 69% of all the B*15-positive samples. In the B62 serologic group,seven alleles were identified, including B*15 : 01, B*1505 ,B * 15:25 ,B * 15:27 ,B * 15:35 ,B* 1: 558. In the B75 serologic group,B*15:02 and B*15:11 were identified in the study samples and B * 15:02 was predominant. Further research is required to identify this unknown allele. Conclusion Our study demonstrates that the high diversity of B* 15 in the GuangDong Han population,and provide that the basic data for the guidance of transfusion and drug hypersensitivity.
机构地区 广州血液中心
出处 《中国输血杂志》 CAS CSCD 北大核心 2012年第7期642-645,共4页 Chinese Journal of Blood Transfusion
基金 国家自然科学基金(No.81102294) 广东省自然科学基金(No.915009505000002) 广州市医药卫生科技重点项目(No.2012A021110002 20121A021008)
关键词 HLA-B*15 等位基因 PCR—SBT 高分辨 基因多态性 HLA-B * 15 gene PCR-SBT High resolution typing Gene polymorphism
  • 相关文献

参考文献3

二级参考文献40

  • 1李焱,汤雪薇,吴洁莹,袁思敏,杨昕,黄以宁,廖灿.广东汉族人群HLA-B基因多态性研究[J].中华医学遗传学杂志,2006,23(1):50-54. 被引量:16
  • 2吴强驹,刘孟黎,齐珺,刘晟,张艳,韦小谦.11755名中国北方汉族造血干细胞供者HLA-A、B、DRB1基因和单倍型研究[J].中国实验血液学杂志,2007,15(2):357-363. 被引量:47
  • 3TENNIS P, STERN R S.Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study [J]. Neurology, 1997, 49(2): 542- 546.
  • 4CHUNG W H, HUNG S I, HONG H S, et al. Medical genetics: a marker for Stevens- Johnson syndrome [J]. Nature, 2004, 428(6982):486.
  • 5HUNG S I, CHUNG W H, JEE S H, et al. Genetic susceptibility to carbamazepine induced cutaneous adverse drug reactions [J]. Pharmacogenet Genomics, 2006, 16 (4) :297-306.
  • 6MAN C B, KWAN P, BAUM L, et al. Association between HLA-B*1502 allele and antiepileptic drug- Induced cutaneous reactions in Han Chinese [J]. Epilepsia, 2007,48(5): 1015- 1018.
  • 7LOCHARERNKUL C, LOPLUMLERT J, LIMOTAI C, et al. Carbamazepinf and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population [J]. Epilepsia, 2008,49(12):2087-2091.
  • 8LONJOU C, THOMAS L, BOROT N, et al.A marker for Stevens- Johnson syndrome: ethnicity matters [J]. Pharmacogenomics J, 2006, 6(4):265-268.
  • 9ALFIREVIC A, JORGENSEN A L, WILLIAMSON P R, et al. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity [J]. Pharmacogenomics, 2006, 7 (6) :813-818.
  • 10KANIWA N, SAITO Y, AIHARA M, et al. HLA-B locus in Japanese patients with anti-ep ileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis [J]. Pharmacogenomics, 2008, 9(11):1617-1622.

共引文献13

同被引文献10

  • 1Parham P, Ohta T. Population biology of antigen presentation by MHC class 1 molecules. Science,1996,272(5258) :67-74.
  • 2Hildebrand WH, Domena JD, Shen SY, et al. HLA-B15 : a wide- spread and diverse family of HLA-B alleles. Tissue Antigens, 1994,43 (4) :209-218.
  • 3Tongio MM, Dormoy A. HLA genotyping: indications and limits. Transfus Clin Biol, 1998,5 ( 1 ) :6-12.
  • 4Wang C, Krishnakumar S, Wilhelmy J, et al. High-throughput, high- fidelity HLA genotyping with deep sequencing. Proc Natl Acad Sci U S A,2012,109(22) :8676-8681.
  • 5Yeung KY, Haynor DR, Ruzzo WL. Validating clustering for gene expression data. Bioinformat,2001,17(4) :309-318.
  • 6Carosella ED. From MAC to HLA : Professor Jean Dansset. Human immunol Proc,2009,70(9) :661-662.
  • 7Marsh S, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens,2004,65 (4) :301-369.
  • 8Solberg OD,Maek SJ, Lancaster AK, et al. Balancing selection and heterogeneity across the classical human leukocyte ant/gen loci : a meta-analytie review of 497 population studies. Hum Immunol, 2008,69(7) :443-464.
  • 9齐珺,刘孟黎,张艳,刘晟,沈春梅.中国北方汉族骨髓供者HLA-B*15组基因多态性的PCR-SBT分型研究[J].中国实验血液学杂志,2008,16(2):429-434. 被引量:7
  • 10罗玫,陈强,陈雪黎,王珏,邹海,徐晓红,梁智恒,陈静娴,郑忠伟.四川骨髓库汉族人群HLA-B^*15等位基因分布[J].中国输血杂志,2008,21(5):352-356. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部